Eris Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Profit before tax

328.83

436.91

458.54

388.89

323.59

Net cashflow-operating activity

336.29

322.33

369.41

395.41

265.19

Net cash used in investing activity

-2,491.89

-513.30

-267.64

-347.86

126.80

Netcash used in fin. activity

2,160.06

193.75

-88.42

-81.13

-333.52

Net inc/dec in cash and equivlnt

4.45

2.78

13.36

-33.58

58.47

Cash and equivalnt begin of year

47.48

44.70

31.35

64.93

6.46

Cash and equivalnt end of year

51.94

47.48

44.70

31.35

64.93